Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis

J Neuropathol Exp Neurol. 2000 Apr;59(4):280-6. doi: 10.1093/jnen/59.4.280.

Abstract

Interferon gamma (IFN-gamma) has been shown to be produced within multiple sclerosis (MS) lesions by infiltrating lymphocytes; systemic administration of this cytokine induces exacerbation of the disease. The aim of the current study was to establish the contribution of IFN-gamma to oligodendrocyte (OL) injury. Our studies utilized cultured human OLs, obtained by dissociation of surgically derived non-MS adult brain tissue. Neither cell survival nor myelin basic protein (MBP) gene expression were affected after 96 hours of treatment with IFN-gamma (100 U/ml), as assessed by LDH release, nucleosome enrichment assay, and RT-PCR. Expression of the death receptor Fas (CD95, APO-1) was, however, significantly increased. Furthermore, IFN-gamma-treated OLs became susceptible to Fas-mediated apoptosis when compared with untreated cells, and were protected by pretreatment with the caspase inhibitor ZVAD. TNF-alpha augmented the IFN-gamma-induced effect. Our results thus indicate that IFN-gamma is not directly cytotoxic for human OLs in culture, but could indirectly modulate functional injury-related responses by upregulating Fas on the cell surface.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antigens, Differentiation / metabolism
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Caspase Inhibitors
  • Cell Membrane / metabolism
  • Cells, Cultured
  • Cysteine Proteinase Inhibitors / pharmacology
  • Drug Synergism
  • Flow Cytometry
  • Humans
  • Interferon-gamma / metabolism*
  • Interferon-gamma / pharmacology
  • L-Lactate Dehydrogenase / metabolism
  • Myelin Basic Protein / genetics
  • Myelin Basic Protein / metabolism
  • Nucleosomes / metabolism
  • Oligodendroglia / cytology
  • Oligodendroglia / drug effects
  • Oligodendroglia / enzymology*
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Necrosis Factor-alpha / pharmacology
  • Up-Regulation / drug effects
  • fas Receptor / genetics
  • fas Receptor / immunology
  • fas Receptor / metabolism*

Substances

  • Antibodies, Monoclonal
  • Antigens, Differentiation
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Myelin Basic Protein
  • Nucleosomes
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • fas Receptor
  • Interferon-gamma
  • L-Lactate Dehydrogenase